Tamotsu Takeuchi Selected Research

Neoplasms (Cancer)

3/2024	Expression of IZUMO2 in colorectal cancer in association with clinicopathological features.
1/2024	Inducing Melanoma Cell Apoptosis by ERp57/PDIA3 Antibody in the Presence of CPI-613 and Hydroxychloroquine.
10/2023	Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer.
9/2023	Prognostic impact of highly solid component in early-stage solid lung adenocarcinoma.
1/2023	Experimental model of micronodular thymic neoplasm with lymphoid stroma.
7/2022	Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review.
1/2021	Combination of Clptm1L and TMEM207 Expression as a Robust Prognostic Marker in Oral Squamous Cell Carcinoma.
1/2021	Human colorectal cancer-associated carbohydrate antigen on annexin A2 protein.
10/2019	An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.
6/2019	CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tamotsu Takeuchi Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 05/2002
13	Carcinogenesis 04/2021 - 09/2003
7	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2002
7	Adenocarcinoma 05/2023 - 09/2003
6	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 09/2003
5	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2015
5	Stomach Neoplasms (Stomach Cancer) 05/2023 - 01/2021
4	Clear Cell Sarcoma 01/2024 - 06/2014
4	Melanoma (Melanoma, Malignant) 01/2024 - 06/2002
4	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 10/2004
4	Signet Ring Cell Carcinoma 11/2019 - 03/2012
4	Gallbladder Neoplasms (Gallbladder Cancer) 12/2012 - 01/2009
4	Leukemia 12/2009 - 06/2006
4	Adenocarcinoma of Lung 06/2006 - 06/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2006 - 01/2003
3	Triple Negative Breast Neoplasms 01/2024 - 07/2023
3	Carcinoma (Carcinomatosis) 05/2023 - 01/2018
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 04/2019
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2018 - 01/2014
3	Synovial Sarcoma (Synovioma) 01/2018 - 02/2002
2	Mesothelioma 01/2022 - 06/2010
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 03/2007
2	Cardiotoxicity 10/2018 - 06/2017
2	Lymphatic Metastasis 01/2018 - 01/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2017 - 06/2017
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2017 - 01/2013
2	Lymphoma (Lymphomas) 10/2017 - 01/2013
2	Neurofibrosarcoma (MPNST) 12/2015 - 05/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2014 - 12/2009
2	Basal Cell Carcinoma (Rodent Ulcer) 05/2014 - 12/2002
2	Lymphadenopathy 07/2012 - 04/2009
2	Hepatocellular Carcinoma (Hepatoma) 01/2011 - 03/2006
2	Lung Neoplasms (Lung Cancer) 01/2007 - 06/2004
1	Malignant Mesothelioma 02/2024
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2023
1	Thymus Neoplasms (Thymus Neoplasm) 01/2023
1	Carcinosarcoma 07/2022
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2002
10	AntibodiesIBA 03/2024 - 06/2006
9	Small Interfering RNA (siRNA)IBA 01/2024 - 03/2007
8	H-cadherin (T-cadherin)IBA 04/2017 - 06/2002
7	AdiponectinIBA 10/2023 - 09/2007
6	Messenger RNA (mRNA)IBA 04/2021 - 01/2006
6	matrigelIBA 01/2021 - 04/2011
6	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2007 - 01/2003
5	Monoclonal AntibodiesIBA 01/2024 - 09/2003
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2024 - 07/2023
3	Estrogen ReceptorsIBA 01/2024 - 07/2023
3	devimistatIBA 01/2024 - 01/2018
3	LigandsIBA 04/2021 - 06/2005
3	WW Domain-Containing OxidoreductaseIBA 01/2021 - 01/2018
3	AntigensIBA 01/2021 - 06/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2018 - 06/2017
3	Vincristine (Oncovin)FDA LinkGeneric 10/2018 - 06/2017
3	pirarubicinIBA 10/2018 - 06/2017
3	Prednisolone (Predate)FDA LinkGeneric 10/2018 - 06/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 06/2017
3	UbiquitinIBA 02/2014 - 05/2005
3	Ligases (Synthetase)IBA 02/2014 - 05/2005
3	CollagenIBA 03/2012 - 01/2009
2	Epidermal Growth Factor (EGF)IBA 10/2023 - 07/2023
2	ErbB Receptors (EGF Receptor)IBA 09/2023 - 03/2006
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2012
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 04/2021 - 01/2019
2	Peptides (Polypeptides)IBA 04/2021 - 01/2007
2	Rituximab (Mabthera)FDA Link 10/2018 - 09/2017
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 01/2013
2	Codon (Codons)IBA 11/2013 - 05/2002
2	AgarIBA 05/2013 - 10/2004
2	Matrix Metalloproteinases (MMPs)IBA 09/2011 - 04/2011
2	Capsules (Microcapsules)IBA 12/2007 - 11/2006
2	Adiponectin ReceptorsIBA 09/2007 - 03/2006
2	AndrogensIBA 06/2006 - 10/2004
2	Human immunodeficiency virus 1 p16 proteaseIBA 07/2005 - 10/2004
2	Caspase 3 (Caspase-3)IBA 10/2004 - 06/2004
2	Cadherins (E-Cadherin)IBA 12/2002 - 06/2002
1	Indicators and Reagents (Reagents)IBA 03/2024
1	AsbestosIBA 02/2024
1	human ERBB2 proteinIBA 01/2024
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2024
1	Carcinoembryonic AntigenIBA 09/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2023
1	Tumor Biomarkers (Tumor Markers)IBA 05/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2022
1	DEET (DET)IBA 07/2022
1	pazopanib FDA Link 07/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2024 - 10/2004
2	Transplantation 01/2023 - 06/2019
2	Drug Therapy (Chemotherapy) 07/2022 - 09/2017
2	VAP-cyclo protocol 06/2017 - 01/2014
2	Boron Neutron Capture Therapy 12/2015 - 06/2014
2	Immunotherapy 01/2007 - 06/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2023
1	Gastrectomy 05/2023
1	Appendectomy 02/2022
1	Ovariectomy (Oophorectomy) 02/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2022